| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.089 | 0.08 |